Related Experiment Video
Updated: Nov 27, 2025

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Low Nitric Oxide Bioavailability Increases Renin Production in the Collecting Duct
Andrew C Curnow1, Sabrina R Gonsalez1,2, Venkateswara R Gogulamudi1
1Department of Physiology, Tulane University School of Medicine, New Orleans, LA, United States.
Low nitric oxide (NO) levels stimulate renin production in the kidney's collecting duct (CD). This finding suggests a new mechanism linking NO, CD-renin, and hypertension development.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Molecular Biology
Background:
- Collecting duct (CD) renin production contributes to hypertension.
- Low nitric oxide (NO) bioavailability in the renal medulla is linked to hypertension.
- The role of NO in regulating CD renin production remains unclear.
Purpose of the Study:
- To investigate the hypothesis that reduced intrarenal NO levels stimulate CD-renin production.
- To elucidate the intracellular mechanisms by which NO influences renin synthesis and secretion in the CD.
Main Methods:
- Examined renin expression in CD-eNOS deficient mice and wild-type littermates.
- Treated M-1 cells with L-NAME (NO synthase inhibitor) and NONOate (NO donor).
- Assessed renin transcript levels, extracellular renin protein, intracellular renin, cGMP, and signaling pathways (guanylyl cyclase, PKG, PKC).
Main Results:
- CD-renin immunoreactivity was elevated in CD-eNOS deficient mice, while juxtaglomerular renin remained unchanged.
- Both L-NAME and NONOate increased intracellular renin protein in M-1 cells.
- L-NAME stimulated renin synthesis and secretion; NONOate induced cGMP mobilization and intracellular renin accumulation, partly mediated by guanylyl cyclase, PKG, and PKC.
Conclusions:
- Low NO bioavailability enhances CD-renin synthesis and secretion.
- This mechanism may contribute to the activation of the intrarenal renin-angiotensin system.
- Findings provide insights into the interplay between NO and the renin-angiotensin system in hypertension.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Vasodilators
Hormonal Regulation

